Activist Short Selling After the Andrew Left Decision: Pt 1
Andrew Left was convicted for trading against his own calls, not for his research, and what the verdict really changes for activist short selling will not be settled until the appeal.
Activ8 Newsroom • June 4, 2026
- The verdict: A jury convicted Andrew Left on thirteen of seventeen counts. The conviction was built on a scalping theory, not a short-and-distort theory. Prosecutors never alleged that Citron's research was false.[1][3]
- What it punishes: The case targeted the gap between what Left said publicly and how he traded, telling followers he was short while he was already covering, and telling them to buy while he was selling.[3]
- What changes immediately: Behavior and perception, not settled law. Investigators are tightening disclosures, moving disclaimers into the body of their reports, and rethinking how they discuss live positions on television and social media.
- What is unresolved: The real precedent will not be clear until the government has to defend its theory before the Ninth Circuit Court of Appeals.
- What does not change: The market function. Even the prosecutor who won the case has said that short selling is not a crime.[2]
The conviction of Andrew Left on June 1, 2026 closed one chapter of the most closely watched legal case in the history of activist short selling and opened a far larger question for everyone else in the field. The question is no longer whether a jury believed Left crossed a line. The jury did. The question now is what every other Investigator has to do differently, and whether the line the government drew will hold up when it is finally tested on appeal.
Conviction
Profits (SEC)
Date
Verdict returned June 1, 2026. Profit figure per the SEC civil complaint.[1][4]
What the Jury Decided, and What It Did Not
The split matters. The jury convicted on the overarching scheme count and on twelve of the sixteen trade-specific counts, while acquitting on four. That is not a blanket condemnation of activist research. It is a jury working through the facts of individual trades and reaching different conclusions on different days.[1][3]
The theory underneath the conviction is the single most important thing for Investigators to understand. Left was not charged with lying about the companies he targeted. He was charged with misrepresenting his own positions. The government's case rested on what prosecutors framed as a scalping pattern, building a position, publishing commentary expected to move the stock, then trading against that commentary within minutes and well short of any published price target. In several counts, the same pattern ran in the other direction, with Left recommending a stock he was already selling. That is why the verdict reaches beyond short sellers to the much larger universe of investors who publicly tout stocks they own.[2][3]
According to the Wall Street Journal, prosecutors argued that Left corrupted a legitimate business model by trading quickly around his own statements, in effect doing the opposite of what his audience expected. His own research was never the target. The conduct was.[2]
What Changes Now
For the individual Investigator
The most immediate effects are practical. Across the field, Investigators are revisiting how they disclose. The lesson many are drawing from the case is to rely on the strength of the research rather than the weight of a reputation, to disclose financing arrangements rather than leave them implied, to place the disclaimer inside the report rather than behind a hyperlink, and to be explicit about risk management rather than silent about why a position changed.
Each of these tracks directly to the case. The court that allowed the parallel civil action to proceed held that the mere existence of a disclaimer does not automatically cure an otherwise misleading statement, which puts pressure on the common practice of linking to boilerplate rather than embedding it.[5] The government also alleged an undisclosed financial relationship with a hedge fund, the kind of balance-sheet financing arrangement that has quietly underpinned the industry for years and that activists are now under pressure to surface.[3][6] And the conduct prosecutors highlighted most vividly was a television appearance in which Left described his position in terms the indictment says did not match his trading. Discipline about how live positions are discussed in public is no longer optional.[3]
For the industry
The structural picture was already contracting before the verdict, and the conviction is widely expected to accelerate it. Hindenburg Research wound down in early 2025, and other prominent names have stepped back from betting against individual companies. The Wall Street Journal, citing data from Breakout Point, reported that the number of activist short firms publishing research has fallen sharply from its 2020 peak.[2] The open question is where the function migrates. Some of it may move toward the whistleblower award programs, where the same investigative work that powers a public report can be filed confidentially with regulators, and some may move toward private litigation or quieter institutional positioning.
The appeal is the real test
None of the changes in perception settle the law. As the case moves to the Ninth Circuit, the questions that matter for the entire industry are whether the court affirms that there is no rule requiring a researcher to hold a position until a published price target is reached, and whether it confirms that harsh opinion that is not defamatory remains protected speech. Until those questions are answered against a developed legal argument rather than a sympathetic set of facts, the precedent is unsettled.
An Attorney's View
Very few attorneys are willing to stand up publicly for activist short sellers, and fewer still have built an entire practice around it. John Sutter is arguably the best attorney defending the rights of activist short sellers. He came to the field through whistleblower work, representing the insiders and researchers who surface corporate fraud for regulators, and over years of that work he came to understand the legal and business needs of short sellers in a way almost no one else does. He has since become one of the few lawyers willing to say plainly that short sellers are not villains but a necessary check on the market, and to defend them on the record. He was quoted in the Wall Street Journal's coverage of the verdict.
In an interview with Activ8 Insights, Sutter argued that the most important near-term effect of the conviction is psychological, and that the market has not yet learned what it actually means.[7]
The full picture, he cautions, will not be clear for some time. As he put it in our interview, "We won't really understand how the risks have changed until the government is forced to defend its case in the Ninth Circuit on appeal."[7]
Sutter argues that the government's theory is internally inconsistent and has never been fully articulated. He points out that prosecutors spent much of the case asserting that Left lied about running a hedge fund with outside investors, then characterized him afterward in terms that imply the obligations of an investment adviser, a posture he considers difficult to reconcile.[7]
He also cautions against reading the verdict as a referendum on the field. In his view, Left was an outlier whose method exposed him in a way the standard model does not. As Sutter put it in our interview, the risk arrives when an Investigator moves away from a well-researched report, summarized in a post and carrying a disclaimer, toward a bare assertion that a company should go to zero. The first is the normal model. The second, he argues, is what created the opening for this prosecution.[7]
What Sutter wants from the appeal is precision. He believes the industry needs a decision tied as tightly as possible to the specific facts of the Left case, one that separates the conduct the government actually proved from the broader activity it rhetorically swept in. His stated goal is that responsible activist short selling emerge from this stronger rather than weaker. Responsible, he is careful to add, does not mean nice.[7]
What Does Not Change
For all the anxiety the verdict has produced, the underlying case for activist short selling is intact. Investigators remain among the most effective fraud detectors in the market, from accounting analysis of established companies to reports exposing businesses that barely exist at all. That work surfaces problems that auditors, regulators, and sell-side analysts routinely miss, and it does so at the expense of the people doing it.
Even the government has been careful to preserve the distinction. The top federal prosecutor in Los Angeles, after the conviction, stated plainly that short selling is not a crime and framed the case as being about a specific manipulative pattern rather than the practice itself.[2] The verdict punished what the jury found to be deception about Left's own trading. It did not, and could not, punish the act of telling the market that an emperor has no clothes.
What to Watch
Sources
- [1]Michelle Celarier, "Andrew Left's Fraud Conviction Raises New Risks for Activist Short Sellers," Institutional Investor, June 3, 2026.
- [2]Dave Michaels and Peter Rudegeair, "A Short Seller's Fraud Conviction Is Spooking Wall Street," The Wall Street Journal, June 3, 2026.
- [3]U.S. Department of Justice, First Superseding Indictment, United States v. Andrew Left, Case No. 2:24-cr-456(A)-VAP, U.S. District Court for the Central District of California, filed February 4, 2026.
- [4]Securities and Exchange Commission, Complaint, SEC v. Andrew Left and Citron Capital, LLC, Case No. 2:24-cv-06311, U.S. District Court for the Central District of California, filed July 26, 2024.
- [5]Bloomberg, "Short Seller Andrew Left Loses Bid to Toss Out SEC Fraud Case," April 23, 2025.
- [6]Michelle Celarier, "The Dark Money Secretly Bankrolling Activist Short Sellers, and the Insiders Trying to Expose It," Institutional Investor, November 30, 2020.
- [7]John Sutter, attorney, interview with Activ8 Insights, June 2026.
More in News
Consolidation Comes to Activist Short Selling
A landmark acquisition, back-to-back collaborative reports, and interviews with investigators point to a shift in how activist short selling gets done.
Activ8 Newsroom • July 7, 2026
The Citron Scorecard: How Andrew Left’s Targets Actually Traded
A great deal has been written about the man. Far less has been written about the numbers. We pulled every Citron Research call in our database and measured what happened to the stocks.
Activ8 Newsroom • June 23, 2026
Andrew Left on Trial: The Case That Could Redefine Activist Short Selling
On May 11, 2026, the federal criminal trial of Andrew Left, founder of Citron Research, opened in Los Angeles, with prosecutors alleging he generated $16 million by trading against the very recommendations he published. It is the first criminal prosecution of an Activist short seller, and its outcome could reshape what every Investigator is permitted to say while holding a position.
Activ8 Newsroom • May 11, 2026